MannKind (Nasdaq:MNKD) is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.
Recent Mentions on Fool.com
- Could Incoming Threats Sink MannKind Corporation?
- MannKind, Front and Center: The Best Product Doesn?t Always Equal the Best Stock
- Forget MannKind Stock's Price: Here's What You Need to Focus on Instead
- 4 Reasons Why MannKind Could Succeed Where Pfizer Failed
- Why MannKind Stock Got New Life Breathed Into It Today